Skip to main content
. 2024 Jul 5;16(7):905. doi: 10.3390/pharmaceutics16070905

Figure 5.

Figure 5

Safety evaluation of DASA+ATO@PLT: (A) schematic of the mechanism by which DASA+ATO@PLT minimizes toxic side effects; (B) H&E staining results of vital organs, including the heart, liver, spleen, lung, and kidney. Scale bar: 100 μm. (C) Measurement of biochemical blood indices, including white blood cell (WBC), neutrophil (NE), lymphocyte (LY), and monocyte (MO) counts and alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and urea nitrogen (BUN).